Feasibility Study of Renal Denervation for the Treatment of Resistant Hypertension
- Conditions
- Uncontrolled Hypertension
- Registration Number
- NCT01865591
- Lead Sponsor
- Sound Interventions, Inc.
- Brief Summary
The aim of this study is to assess the potential therapeutic benefit of catheter-based renal sympathetic denervation using therapeutic unfocussed ultrasound in a single-arm feasibility trial.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 30
- Uncontrolled hypertension (defined as SBP ≥ 140 mmHg during 24Hr Ambulatory BP monitoring)
- Current treatment with ≥ 3 anti-hypertensive drugs (including at least one diuretic)
- Renal artery diameter ≥5mm by digital angiography
- Accessibility of renal vasculature
- Estimated GFR < 45
- Type 1 Diabetes
- Known renovascular abnormalities (eg, renal artery stenosis, previous renal artery stenting or angioplasty)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Major adverse events 30 days All cause death, renal artery occlusion, renal artery stenosis, renal infarction and/or renal failure
- Secondary Outcome Measures
Name Time Method Adverse events and device complications 12 months Change from baseline in creatinine 6 months Change from baseline in office blood pressure measurement 30 days, 3 months, 6 months, 9 months, 12 months Change from baseline in ambulatory 24-hour blood pressure measurement 6 months, 12 months Change from baseline in renal artery dimensions 30 days Change in renal artery dimensions as measured by renal angiography, CT, or MRI
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Na Homolce Hospital
🇨🇿Prague, Czech Republic
Na Homolce Hospital🇨🇿Prague, Czech RepublicLiz ColingContactliz.coling@homolka.czPetr Neuzil, MD PhD FESCPrincipal Investigator